Showing results (831-840 of 1,120) with videos related to

Sort By:
Pageof 112
American Journal of Preventive Cardiology|August 14, 2025
Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trialAdam J Nelson, Lisa A Kaltenbach, Hussein R Al-Khalidi, et al.
Annals of Internal Medicine|September 30, 2024
Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia : A Target Trial Emulation Using MINT Trial DataGerard T Portela, Jeffrey L Carson, Sonja A Swanson, et al.
Nature Communications|April 19, 2018
Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditisMaria C Silva, Marcela Davoli-Ferreira, Tiago S Medina, et al.
The Lancet. Diabetes & Endocrinology|February 17, 2025
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trialRahul Aggarwal, Deepak L Bhatt, Michael Szarek, et al.
European Journal of Heart Failure|December 26, 2024
Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trialMark C Petrie, Jacob A Udell, Stefan D Anker, et al.
The Lancet. Neurology|January 25, 2025
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trialAshkan Shoamanesh, Thalia S Field, Shelagh B Coutts, et al.
American Heart Journal|November 23, 2022
Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trialJeffrey L Carson, Maria Mori Brooks, Bernard R Chaitman, et al.
ESC Heart Failure|September 15, 2025
Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MIFrancesco Fioretti, Javed Butler, Jacob A Udell, et al.
NEJM Evidence|December 23, 2024
Restrictive versus Liberal Transfusion in Myocardial Infarction - A Patient-Level Meta-AnalysisJeffrey L Carson, Dean A Fergusson, Helaine Noveck, et al.
Circulation|June 27, 2024
Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes TrialManasi Tannu, Lisa Kaltenbach, Neha J Pagidipati, et al.
Pageof 112